Non-small-cell lung cancer in the elderly with an emphasis on chemotherapy in the adjuvant and metastatic disease settings

Smitha P. Menon, Aminah Jatoi

Research output: Contribution to journalReview article

Abstract

Most lung cancer patients in the USA are older than 65 years of age, and yet oncologists continue to struggle with how best to treat these older patients. This article reviews the medical management of non-small-cell lung cancer in older patients with a focus on decision-making with respect to chemotherapy in the adjuvant setting and metastatic disease settings. In these two settings, chemotherapy as a single-modality intervention can provide a major positive impact. Nonetheless, a relative dearth of evidence in these settings underscores the need to summarize the available data in an effort to make patient counseling easier for healthcare providers and to make decision-making easier for patients and their families.

Original languageEnglish (US)
Pages (from-to)411-416
Number of pages6
JournalLung Cancer Management
Volume3
Issue number5
DOIs
StatePublished - Oct 1 2014

Keywords

  • adjuvant
  • combination chemotherapy
  • elderly
  • metastatic
  • non-small-cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Non-small-cell lung cancer in the elderly with an emphasis on chemotherapy in the adjuvant and metastatic disease settings'. Together they form a unique fingerprint.

  • Cite this